MXPA03001930A - Moleculas pseudorreceptoras de factor de necrosis tumoral y uso de las mismas. - Google Patents
Moleculas pseudorreceptoras de factor de necrosis tumoral y uso de las mismas.Info
- Publication number
- MXPA03001930A MXPA03001930A MXPA03001930A MXPA03001930A MXPA03001930A MX PA03001930 A MXPA03001930 A MX PA03001930A MX PA03001930 A MXPA03001930 A MX PA03001930A MX PA03001930 A MXPA03001930 A MX PA03001930A MX PA03001930 A MXPA03001930 A MX PA03001930A
- Authority
- MX
- Mexico
- Prior art keywords
- polypeptides
- molecules
- tnf receptor
- methods
- amelioration
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 239000011230 binding agent Substances 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Peptides Or Proteins (AREA)
- Physical Education & Sports Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23019100P | 2000-09-05 | 2000-09-05 | |
| PCT/US2001/027631 WO2002020762A2 (en) | 2000-09-05 | 2001-09-05 | Tnf receptor-like molecules and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03001930A true MXPA03001930A (es) | 2003-06-19 |
Family
ID=22864263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03001930A MXPA03001930A (es) | 2000-09-05 | 2001-09-05 | Moleculas pseudorreceptoras de factor de necrosis tumoral y uso de las mismas. |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US7153669B2 (enExample) |
| EP (1) | EP1317536B1 (enExample) |
| JP (1) | JP2004508043A (enExample) |
| AT (1) | ATE431405T1 (enExample) |
| AU (2) | AU2001288812B2 (enExample) |
| CA (1) | CA2421588C (enExample) |
| DE (1) | DE60138715D1 (enExample) |
| ES (1) | ES2327102T3 (enExample) |
| MX (1) | MXPA03001930A (enExample) |
| WO (1) | WO2002020762A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1424392B1 (en) * | 2001-09-03 | 2012-10-24 | Takeda Pharmaceutical Company Limited | RF-peptide ligands of G-protein coupled receptor |
| EP1338609A1 (de) * | 2002-02-21 | 2003-08-27 | MEMOREC Stoffel GmbH-Medizinisch-Molekulare Entwicklung, Köln | Ein weiterer KDR Rezeptor und seine Anwendung |
| CA3066594A1 (en) * | 2004-10-08 | 2006-04-20 | Georgia Tech Research Corporation | Microencapsulation of cells in hydrogels using electrostatic potentials |
| SG176963A1 (en) | 2009-06-22 | 2012-02-28 | Amgen Inc | Refolding proteins using a chemically controlled redox state |
| LT3660032T (lt) | 2009-06-25 | 2026-02-25 | Amgen Inc. | Ne žinduolių sistemoje ekspresuotų baltymų surišamojo gryninimo būdai |
| EP2507267B1 (en) | 2009-12-02 | 2016-09-14 | Acceleron Pharma, Inc. | Compositions and methods for increasing serum half-life of fc fusion proteins |
| ES2592937T3 (es) | 2010-12-02 | 2016-12-02 | F. Hoffmann-La Roche Ag | Anticuerpos que bloquean la interacción entre IGFL1 y TMEM149 |
| US8883982B2 (en) | 2011-06-08 | 2014-11-11 | Acceleron Pharma, Inc. | Compositions and methods for increasing serum half-life |
| UY35148A (es) | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| WO2014144817A2 (en) | 2013-03-15 | 2014-09-18 | Amgen Inc. | Inhibitory polypeptides specific to wnt inhibitors |
| EP3712166A1 (en) | 2013-09-05 | 2020-09-23 | Amgen Inc. | Fc-containing molecules exhibiting predictable, consistent, and reproducible glycoform profiles |
| WO2015175861A1 (en) | 2014-05-16 | 2015-11-19 | Amgen Inc. | Assay for detecting th1 and th2 cell populations |
| AU2018235928B2 (en) | 2017-03-14 | 2023-09-21 | Amgen Inc. | Control of total afucosylated glycoforms of antibodies produced in cell culture |
| US12325737B2 (en) | 2018-03-26 | 2025-06-10 | Amgen Inc. | Total afucosylated glycoforms of antibodies produced in cell culture |
| KR20220069982A (ko) | 2019-09-26 | 2022-05-27 | 암젠 인크 | 항체 조성물의 생산 방법 |
| EP4045515A4 (en) | 2019-10-18 | 2023-10-18 | The Regents Of The University Of Michigan | BIOMATERIAL SENSOR SYSTEMS |
| IL293640A (en) * | 2019-12-20 | 2022-08-01 | Amgen Inc | CD40 antagonistic mesothelin-targeted multispecific antibody constructs for the treatment of solid tumors |
| WO2021247892A1 (en) | 2020-06-04 | 2021-12-09 | Amgen Inc. | Assessment of cleaning procedures of a biotherapeutic manufacturing process |
| US20240043501A1 (en) | 2020-10-15 | 2024-02-08 | Amgen Inc. | Relative unpaired glycans in antibody production methods |
| AU2022289365A1 (en) | 2021-06-07 | 2023-12-14 | Amgen Inc. | Using fucosidase to control afucosylation level of glycosylated proteins |
| JP2024537100A (ja) | 2021-10-05 | 2024-10-10 | アムジエン・インコーポレーテツド | Ｆｃガンマ受容体ＩＩ結合、及びグリカン含量 |
| WO2023215725A1 (en) | 2022-05-02 | 2023-11-09 | Fred Hutchinson Cancer Center | Compositions and methods for cellular immunotherapy |
| JP2026516670A (ja) | 2023-04-20 | 2026-05-26 | アムジエン・インコーポレーテツド | 相対的な不対グリカン含有量を決定する方法 |
| CN116459344B (zh) * | 2023-04-28 | 2025-03-18 | 上海市生物医药技术研究院 | 一种MNSFβ/RC3H1 PPI干扰多肽的抗炎治疗应用 |
| AU2024325342A1 (en) | 2023-08-14 | 2026-02-26 | Amgen Inc. | Methods for reducing yellow color |
| WO2025101820A1 (en) | 2023-11-08 | 2025-05-15 | Fred Hutchinson Cancer Center | Compositions and methods for cellular immunotherapy |
| WO2026090253A1 (en) | 2024-10-23 | 2026-04-30 | Amgen Inc. | Methods of determining glycan pairing content |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59010941D1 (de) | 1989-04-21 | 2005-03-24 | Amgen Inc | TNF-Rezeptor, TNF bindende Proteine und dafür kodierende DNAs |
| IL95031A (en) | 1989-07-18 | 2007-03-08 | Amgen Inc | Method for the production of a human recombinant tumor necrosis factor inhibitor |
| US5194596A (en) * | 1989-07-27 | 1993-03-16 | California Biotechnology Inc. | Production of vascular endothelial cell growth factor |
| US5350836A (en) * | 1989-10-12 | 1994-09-27 | Ohio University | Growth hormone antagonists |
| DE4004317A1 (de) | 1990-02-13 | 1991-08-14 | Basf Ag | Neue 3-substituierte pyridinmethanole und diese enthaltende fungizide |
| US6641809B1 (en) * | 1990-03-26 | 2003-11-04 | Bristol-Myers Squibb Company | Method of regulating cellular processes mediated by B7 and CD28 |
| US5843789A (en) * | 1995-05-16 | 1998-12-01 | Neomecs Incorporated | Method of analysis of genomic biopolymer and porous materials for genomic analyses |
| WO1999047535A1 (en) * | 1998-03-16 | 1999-09-23 | Millennium Pharmaceuticals, Inc. | METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| US6660843B1 (en) * | 1998-10-23 | 2003-12-09 | Amgen Inc. | Modified peptides as therapeutic agents |
| WO2001055448A1 (en) | 2000-01-31 | 2001-08-02 | Human Genome Sciences, Inc. | Nucleic acids, proteins, and antibodies |
| US6783969B1 (en) * | 2001-03-05 | 2004-08-31 | Nuvelo, Inc. | Cathepsin V-like polypeptides |
-
2001
- 2001-09-05 ES ES01968572T patent/ES2327102T3/es not_active Expired - Lifetime
- 2001-09-05 WO PCT/US2001/027631 patent/WO2002020762A2/en not_active Ceased
- 2001-09-05 EP EP01968572A patent/EP1317536B1/en not_active Expired - Lifetime
- 2001-09-05 AU AU2001288812A patent/AU2001288812B2/en not_active Ceased
- 2001-09-05 AT AT01968572T patent/ATE431405T1/de not_active IP Right Cessation
- 2001-09-05 CA CA2421588A patent/CA2421588C/en not_active Expired - Fee Related
- 2001-09-05 DE DE60138715T patent/DE60138715D1/de not_active Expired - Lifetime
- 2001-09-05 JP JP2002525769A patent/JP2004508043A/ja active Pending
- 2001-09-05 MX MXPA03001930A patent/MXPA03001930A/es active IP Right Grant
- 2001-09-05 AU AU8881201A patent/AU8881201A/xx active Pending
- 2001-09-05 US US09/948,018 patent/US7153669B2/en not_active Expired - Fee Related
-
2006
- 2006-05-17 US US11/436,207 patent/US7569387B2/en not_active Expired - Fee Related
-
2009
- 2009-06-19 US US12/488,330 patent/US20090325880A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002020762A3 (en) | 2002-08-08 |
| AU8881201A (en) | 2002-03-22 |
| JP2004508043A (ja) | 2004-03-18 |
| US20090325880A1 (en) | 2009-12-31 |
| US20020150977A1 (en) | 2002-10-17 |
| EP1317536B1 (en) | 2009-05-13 |
| ATE431405T1 (de) | 2009-05-15 |
| ES2327102T3 (es) | 2009-10-26 |
| US7153669B2 (en) | 2006-12-26 |
| EP1317536A2 (en) | 2003-06-11 |
| AU2001288812B2 (en) | 2007-05-10 |
| WO2002020762A2 (en) | 2002-03-14 |
| DE60138715D1 (de) | 2009-06-25 |
| US7569387B2 (en) | 2009-08-04 |
| CA2421588A1 (en) | 2002-03-14 |
| US20070015219A1 (en) | 2007-01-18 |
| WO2002020762A8 (en) | 2004-03-04 |
| CA2421588C (en) | 2010-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU8881201A (en) | Tnf receptor-like molecules and uses thereof | |
| MXPA02012743A (es) | Moleculas tipo il-17 y usos de las mismas. | |
| MXPA03002413A (es) | Moleculas tipo b7 y uso de las mismas. | |
| WO2001092308A3 (en) | Cystine-knot polypeptides: cloaked-2 molecules and uses thereof | |
| WO2002002624A3 (en) | B7-like molecules and uses thereof | |
| WO2001072957A3 (en) | Fibroblast growth factor-like molecules and uses thereof | |
| WO2001070977A3 (en) | Fibroblast growth factor receptor-like molecules and uses thereof | |
| WO2001068859A3 (en) | Il-17 receptor like molecules and uses thereof | |
| WO2002000724A3 (en) | Thymic stromal lymphopoietin receptor molecules and uses thereof | |
| WO2000040614A3 (en) | Characterization of the soc/crac calcium channel protein family | |
| WO2001068705A3 (en) | Il-17 receptor like molecules and uses thereof | |
| WO2001061007A3 (en) | Fibroblast growth factor-23 molecules and uses thereof | |
| WO2001068854A3 (en) | Fibroblast growth factor-like molecules and uses thereof | |
| MXPA03000979A (es) | Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas. | |
| WO2000053776A3 (en) | Human kallikrein-like genes | |
| WO2003024991A3 (en) | Tall-1 receptor molecules and uses thereof | |
| WO2001042474A3 (en) | Interferon-like molecules and uses thereof | |
| WO2002000723A3 (en) | Thymic stromal lymphopoietin receptor molecules and uses thereof | |
| PL374550A1 (en) | Il-17 like molecules and uses thereof | |
| WO2001074903A3 (en) | Cd20/ige-receptor like molecules and uses thereof | |
| MXPA03010728A (es) | Moleculas de proteina-2 relacionadas con b7 y uso de las mismas. | |
| WO2005023979A3 (en) | Isolated s. mansoni nucleic acid molecules and uses thereof | |
| MXPA03000980A (es) | Moleculas tipo receptor de complemento c3b/c4b y usos de las mismas. | |
| WO2002014489A3 (en) | Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof | |
| WO2002099108A3 (en) | Atp-binding cassette transporter-like molecules and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |